ITGAX and central nervous system cancer: Among these, 9 immune cell types, such as CD19 on IgD( +) CD24(−), were identified as risk factors for glioma (Supplementary Fig. 1), while 10 immune cell types, such as CD11c on monocyte, were considered protective factors for glioma (Supplementary Fig. 2).